Problem
25% of heart-failure patients are readmitted within 30 days, costing US hospitals $17bn a year.

Remote heart monitoring that spots warning signs early and alerts the patient's care team before a hospital visit is needed.
One in four heart-failure patients is readmitted to hospital within 30 days of going home. Most of those readmissions follow warning signs, such as weight gain, breathlessness and rhythm changes, that nobody saw in time.
Pulsebridge gives patients a small chest patch and a connected scale. Our software watches the readings around the clock and alerts the care team when something changes, so a nurse can call, adjust medication or book a visit before things get worse.
25% of heart-failure patients are readmitted within 30 days, costing US hospitals $17bn a year.
A chest patch and connected scale with software that flags early warning signs to nurses.
Hospital cardiology departments and cardiology practices in the US. 6.7 million Americans live with heart failure.
Monthly fee per monitored patient, mostly reimbursed under Medicare remote monitoring codes. USD 120 per patient per month.
BioTelemetry, Biofourmis and in-house nurse call programmes. Our alerts are 40% more accurate than weight-only rules in a 400-patient study.
Start with 3 hospital systems in New England, then expand through a medical device distributor.
Raising USD 2.5m seed. FDA 510(k) submission, clinical team and two new hospital launches.
Readmissions down 31% in a 400-patient pilot
3 hospital systems signed
Two cardiologists on the founding team
Patent filed on our alert model
25% of heart-failure patients are readmitted within 30 days, costing US hospitals $17bn a year.
A chest patch and connected scale with software that flags early warning signs to nurses.
Hospital cardiology departments and cardiology practices in the US.
6.7 million Americans live with heart failure.
Start with 3 hospital systems in New England, then expand through a medical device distributor.
Monthly fee per monitored patient, mostly reimbursed under Medicare remote monitoring codes.
USD 120 per patient per month.
BioTelemetry, Biofourmis and in-house nurse call programmes.
Our alerts are 40% more accurate than weight-only rules in a 400-patient study.
Raising USD 2.5m seed.
FDA 510(k) submission, clinical team and two new hospital launches.
Pulsebridge is led by Hannah Brooks (Co-founder & CEO), Ben Lindgren (Co-founder & CTO), Kavya Moreau (Chief Operating Officer). The team combines deep industry experience with a track record of shipping products customers love.

Co-founder & CEO
Hannah founded Pulsebridge and leads strategy, fundraising and the team. Former lead engineer at a well-known software company.
LinkedIn profile
Co-founder & CTO
Ben leads the technology and engineering team. Previously founded and sold a small marketing agency.
LinkedIn profile
Chief Operating Officer
Kavya runs day-to-day operations and customer delivery. Has ten years of experience in the industry across three continents.

Head of Product
Pablo owns the product roadmap and user research. Previously spent six years at a Big Four consultancy.
LinkedIn profile
Head of Growth
Mira leads marketing, partnerships and customer acquisition. Previously built payment systems at a European fintech.
No questions yet
Be the first to ask Pulsebridge a question. Answers are public.
$2,500,000
for 11% equity · min $50,000